References
- Komajda M , HanonO , HochadelMet al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur. Heart J. 30 ( 4 ), 478 – 486 ( 2009 ).
- Manzano L , EscobarC , ClelandJG , FlatherM. Diagnosis of elderly patients with heart failure.Eur. J. Heart Fail.14 ( 10 ), 1097 – 1103 ( 2012 ).
- Van Tassell BW , ArenaRA , ToldoSet al. Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure. PLoS ONE 7 ( 3 ), e33438 ( 2012 ).
- Ky B , FrenchB , LevyWCet al. Multiple biomarkers for risk prediction in chronic heart failure. Circ. Heart Fail. 5 ( 2 ), 183 – 190 ( 2012 ).
- Paulus WJ , TschopeC , SandersonJEet al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 28 ( 20 ), 2539 – 2550 ( 2007 ).
- Ma LP , HaugenE , IkemotoM , FujitaM , TerasakiF , FuM. S100A8/A9 complex as a new biomarker in prediction of mortality in elderly patients with severe heart failure.Int. J. Cardiol.155 ( 1 ), 26 – 32 ( 2012 ).
- Alehagen U , DahlströmU , RehfeldJF , GoetzeJP. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.JAMA305 ( 20 ), 2088 – 2095 ( 2011 ).
- Alehagen U , DahlströmU , LindahlTL. Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care.Eur. J. Heart Fail.11 ( 4 ), 354 – 360 ( 2009 ).
- Nymo SH , HultheJ , UelandTet al. Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA. Eur. J. Heart Fail. 16 ( 1 ), 68 – 75 ( 2014 ).
- Stanciu AE , VatasescuRG , StanciuMM , IorgulescuC , VasileAI , DorobantuM. Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects.Clin. Biochem.46 ( 3 ), 230 – 234 ( 2013 ).
- Krum H , AbrahamWT. Heart failure.Lancet373 ( 9667 ), 941 – 955 ( 2009 ).